Top 5 Heal Care Stocks To Watch For 2015


U.S. stocks have posted gains in six of the last seven trading sessions, but they opened lower today, with the S&P 500 (SNPINDEX: ^GSPC  ) and the narrower, price-weighted Dow Jones Industrial Average (DJINDICES: ^DJI  ) down 0.39% and 0.5%, respectively, at 10:05 a.m. EDT.

Better Fed than red
All eyes on the Fed! The Federal Open Market Committee’s regular two-day meeting begins today. The FOMC is responsible for setting U.S. monetary policy, including interest rates. Here are three things investors should keep in mind. If you only have time to read one, skip straight to No. 3:


1. The Fed will not raise rates at this meeting, nor anytime soon.
We know this is true because the Fed’s stance on rates is well telegraphed. As the statement from the previous FOMC meeting indicated:

“In particular, the Committee decided to keep the target range for the federal funds rate at 0 to 1/4 percent and currently anticipates that this exceptionally low range for the federal funds rate will be appropriate at least as long as the unemployment rate remains above 6-1/2 percent, inflation between one and two years ahead is projected to be no more than a half percentage point above the Committee’s 2 percent longer-run goal, and longer-term inflation expectations continue to be well anchored.”

Top 5 Heal Care Stocks To Watch For 2015: Exone Co (XONE)


The ExOne Company, incorporated on December 21, 2012, is engaged in manufacturing and selling three-dimensional (3D) printing machines and printing products to specification for its customers using its in-house 3D printing machines. The Company provides 3D printing machines, 3D printed products and related services to industrial customers in the aerospace, automotive, heavy equipment, energy/oil/gas and other industries. It offers pre-production collaboration and print products for customers through its production service centers (PSCs), which are located in the United States, Germany and Japan. On January 1, 2013, the Company merged its predecessor company, The Ex One Company, LLC, with and into EXO Acquisitions Inc., which changed its name to The ExOne Company.


The Company produces an array of materialization systems to support a range of customer needs and facility requirements. It offers two printers on the world market for 3D printing of sand and metal ma terials, offering build sizes as large as 1800 x 1000 x 700 mm (70 x 39 x 27 in.) for sand and 780 x 400 x 400 mm (30.7 x 15.75 x 15.75 in.) for metal. It also offers Orion short pulse laser systems, utilizing a five-axis machine tool with four additional axes available on the trepanning head. The Company builds 3D printing machines at its facilities in the United States and Germany. The Company also supplies the associated products, including consumables and replacement parts, and services, including training and technical support, necessary for purchasers of its machines to print products. The Companys 3D printing machines are able to manufacture casting molds and cores from specialty silica sand and ceramics, which are the traditional materials for these casting products.


The Company competes with 3D Systems Corporation, Stratasys Inc., Solidscape, Inc. and Objet Ltd., EOS Optronics GmbH, EnvisionTEC GmbH, and Solid Model Ltd.

Advisors’ Opinion:

  • [By Sue Chang and Ben Eisen]

    Shares of Voxeljet AG (VJET) , a German 3D printing technology company, soared 122% on their first day of trading. Voxeljet priced 6.5 million shares at $13 each. Shares of other 3D printing companies also rose, with ExOne Co. (XONE) 2.9% higher, Stratasys Ltd. (SSYS) up 1.1% and 3D Systems Corp. (DDD) edging up less than 0.1%.

  • [By Paul Ausick]

    Short interest in The ExOne Co. (NASDAQ: XONE) fell 9.5% to 3.33 million shares. About 32.7% of the company’s shares are now held short. Shares of ExOne were down about 1.6% in the two-week period and closed at $58.35 Thursday, up about 130% year to date. The stock’s 52-week range is $23.50 to $78.80.

  • [By David Zeiler]

    4. The ExOne Co. (Nasdaq: XONE): ExOne makes 3D printers and 3D printing products, and anyone who follows tech knows the enormous potential of 3D printing. The company went public February 7 at $18 a share and rose 47.3% on its first day. XONE currently trades at about $51.83, for a total gain of 187.94%.

Top 5 Heal Care Stocks To Watch For 2015: Consumer Portfolio Services Inc.(CPSS)


Consumer Portfolio Services, Inc. operates as a specialty finance company in the United States. It engages in purchasing and serving retail automobile contracts originated by franchised automobile dealers and select independent dealers in the sale of new and used automobiles, light trucks, and passenger vans. The company, through its automobile contract purchases, provides indirect financing to dealer customers for borrowers with limited credit histories, low incomes, or past credit problems. It serves as an alternative source of financing for dealers, allowing sales to customers who might not be able to obtain financing. The company also directly finances consumers for vehicle purchases. Consumer Portfolio Services, Inc. provides its automobile contracts through its headquarters and three servicing branches in Virginia, Florida, and Illinois. The company was founded in 1991 and is headquartered in Irvine, California.


Advisors’ Opinion:

  • [By Rick Munarriz]

    Finally, we have Consumer Portfolio Services (NASDAQ: CPSS  ) driving past where the pros were parked. Consumer Portfolio Services provides indirect automobile financing, primarily to folks with dodgy credit histories buying late-model used cars. This is a risky niche when the economy’s souring, but business is booming these days.

Best Biotech Stocks To Own Right Now: Magna International Inc (MGA)


Magna International Inc. (Magna), incorporated on November 16, 1961, is a diversified global automotive supplier. The Company designs, develops and manufactures automotive systems, assemblies, modules and components, and engineers and assembles complete vehicles, primarily for sale to original equipment manufacturers of cars and light trucks. Its capabilities include interior systems, exterior systems, seating systems, powertrain systems, closure systems, roof systems, body and chassis systems, vehicle engineering and contract assembly, vision systems, hybrid and electric vehicles/systems, electronic systems, and through its Magna E-Car Systems partnership (E-Car Systems). Magna operates in three geographic reporting segments: North America, Europe and Rest of World. In January 2011, the Company acquired Automobiltechnik Durbheim, a manufacturer of tapping plates, which assist in the fastening of bolts. The acquired business is located in Germany and has sales to various a utomobile manufacturers. In May 2011, it acquired a 51% interest in Wuhu Youth Tongyang Auto Plastic Parts Co., Ltd., a supplier of exterior products, mainly front and rear bumpers. In June 2011, it acquired Continental Plastics Co., a supplier of interior products, mainly door panel and seat back assemblies. In August 2011, it acquired Grenville Castings Ltd. In November 2011, Magna acquired ThyssenKrupp Automotive Systems Industrial do Brasil Ltda. In November 2012, the Company’s Magna Powertrain operating unit had completed the transaction to acquire ixetic Verwaltungs GmbH (ixetic).


The Companys North American production sales accounted for approximately 49% of its consolidated sales during the year ended December 31, 2011. Its primary customers in North America in 2011, included BMW, Daimler, Fiat/Chrysler Group, Ford, General Motors, Honda, Hyundai-Kia Group, Mazda, Renault-Nissan, Toyota and Volkswagen Group. Its European production and vehicle assembl y sales accounted for approximately 39% of its consolidated ! sales during 2011. Magnas primary customers in Europe in 2011, included Aston Martin, BMW, Daimler, Fiat/Chrysler Group, Ford, Geely Group, General Motors, Honda, Hyundai-Kia Group, PSA Peugeot Citroen, Renault-Nissan, Tata Motors, Toyota, and Volkswagen Group. The Companys Rest of World production sales accounted for approximately 5% of the Companys consolidated sales in 2011, respectively. Its primary customers in Rest of World in 2011, included Brilliance Auto, BMW, Chery Automobile, Daimler, Fiat/Chrysler Group, First Automobile Works, Ford, Geely Group, General Motors, Great Wall Motor Company, Guangzhou Automobile, Honda, Hyundai-Kia Group, PSA Peugeot Citroen, Renault-Nissan, Shanghai Automotive, Suzuki, Tata Motors, Toyota, Volkswagen Group and Yulon Motors.


Interior Systems

The Company designs, engineers and manufactures interior components and systems for the global automotive industry. The primary technologies and processes invo lved in the manufacturing of interior components and systems include low pressure and injection molding, compression molding, vacuum forming, slush molding, spray urethane and manual and automated assembly and sequencing. Its capabilities include sidewall and trim systems, overhead systems, cargo management systems and cockpit systems.

Seating Systems

It develops and manufactures seating solutions and seat hardware systems for the global automotive industry. Its capabilities range from market and consumer research, full concept development, design and engineering, testing and validation to manufacturing. Its capabilities include complete seating systems, seat structures and mechanisms and foam and trim products. The technologies and processes used in the manufacture of seating and seat hardware systems include traditional cut and sew technology; manual and automated assembly, as well as its Multi-Material Mold-In-Place technology.


Closu re Systems

Magna engineers and manufactures cl! osure sys! tems and modules for the global automotive industry. Its capabilities include door modules, window systems, power closure systems, latching systems, driver controls, electronic features and handle assemblies. The primary processes involved in the manufacture of closure systems and modules include light stamping; injection molding, as well as manual and automated assembly.

Body and Chassis Systems

The Company provides metal body systems, components, assemblies and modules, including complete vehicle frames, chassis systems and body-in-white systems, as well as related engineering services, for the global automotive industry. Magna employs a number of different forming technologies, such as hydroforming; stamping; hot stamping; roll forming; aluminum casting; draw bending; advanced welding technologies; as well as finishing technologies such as: e-coating; heat treating, and high temperature wax coating.


Vision Systems

The C ompany designs, engineers and manufactures vision systems for the global automotive industry. Its vision systems capabilities include interior mirrors, exterior mirrors, electronic vision systems and actuators. The primary processes involved in the manufacture of its vision products include electronics integration; injection molding; painting, as well as manual and automated assembly.

Electronic Systems

The Company designs, engineers and manufactures electronic components and sub-systems for the global automotive industry. Its capabilities include driver assistance and safety systems, engine electronics and sensors, body systems and human-machine interfaces (HMI), intelligent power systems and industrial products. The primary processes involved in the manufacture of electronics products include surface mount placements of electronic components on printed circuit boards, as well as manual and automated assembly of electronic modules.


Ex terior Systems

Magna designs, engineers and ma! nufacture! s various exterior components and systems for the global automotive and commercial truck product markets. Its capabilities include front and rear fascia systems, class a composite panels, structural components, sealing systems, modular systems, under hood and underbody components, exterior trim, engineered glass and sheet molding compound material. It utilizes a number of different technologies and processes in connection with these products, including molding technologies, such as injection molding, structural reaction injection, reaction injection, compression and thermoset molding; metal forming processes, such as metal stamping, roll forming, tube forming and stretch bending; extrusion processes, such as co-extrusion, thermoset and thermoplastic extrusion; and finishing processes, including painting, hardcoating, chrome plating, vacuum metallization and anodizing, and manual and automated assembly and sequencing.


Powertrain Systems

Magna design s, engineers and manufactures powertrain systems and components for the global automotive industry. Its capabilities are driveline systems, fluid pressure systems, metal-forming solutions and engineering services and system integration. It employs a variety of different manufacturing capabilities and processing technologies in its powertrain operations, including metal die-forming; flow-forming; stamping and spinning; synchronous roll-forming; die-spline rolling; precision-heavy stamping; fineblanking; aluminum die casting and precision machining; magnesium machining; plastic injection molding and plastic welding; soft and hard processing of gear wheels and shafts; rotary swaging; hardening; laser welding; manual and automated assembly, and end-of-line testing.


The Company y conducts some of its powertrain operations through joint ventures, including a non-controlling, 76.7% equity partnership interest in the Litens Automotive Partnership, which is a supplier o f drive subsystems and components. Product offerings include! accessor! y drive systems and products, including auto tensioners and idlers, overrunning alternator decoupler assemblies, Torqfiltr crankshaft vibration control technology, isolating crank pulley assemblies and clutched waterpump pulleys and assemblies; timing drive systems and products, including tensioners (both for belt and chain) and idlers, SmartSprocket tuned sprockets and clutched waterpump pulleys and assemblies, and other specialty products, including vehicle start/stop subsystems. Litens has manufacturing operations in North America (Canada), Europe (Germany) and Rest of World (China, Brazil and India).


Roof Systems

The Company designs, engineers and manufactures vehicle roof systems for the global automotive industry. Its capabilities are retractable hard tops, soft tops and sliding folding and modular roofs.

Vehicle Engineering and Contract Assembly

Magna provides components, systems and vehicle engineering and contrac t vehicle assembly services for the automotive industry. It is also the brand-independent assembler of complete vehicles and an engineering and manufacturing partner in the field of fuel systems. Its capabilities include engineering services, contract manufacturing and fuel systems. Processes employed in its vehicle engineering and contract assembly operations include manual and automated welding; bonding and riveting; manual and automated painting/coating (dipped and sprayed) and sealing, as well as manual and automated assembly.


Hybrid and Electric Vehicles/Systems

Magna develops, manufactures and integrates hybrid and electric products and vehicle systems through E-Car Systems. Its capabilities under the Hybrid and Electric Vehicles/Systems include components, batteries and vehicle systems. Processes employed in its hybrid and electric vehicles/systems operations include manual and automated assembly; surface mount assembly; wave soldering and po int-to-point solder assembly; automated servo changeover for! surface ! mount technology conveyance; stator winding, wire lead fusing, end turn blocking and lacing; rotor core assembly, magnetization and balancing; laser and ultrasonic welding, and dynamometer testing.


Tooling, Engineering and Other

Magna designs, engineers and manufactures tooling for our own use, as well as for sale to its customers. Additionally, the Company provides engineering support services, independent of particular production programs on which it may have production sales.

Advisors’ Opinion:

  • [By Rich Duprey]

    At some point, there comes a time to pursue interests beyond your job. For Herbert Demel, chief strategy officer at auto parts supplier Magna International (NYSE: MGA  ) , who turns 60 this year,that time is now.

  • [By Gordon Pape]

    The company is not as well-known as competitor Magna International (MGA), but it is highly successful and employs 17,600 people in North America, Europe, and Asia. It has 40 manufacturing locations, five research and development centers, and 15 sales offices in 12 countries.

  • [By Rich Smith]

    Shares of auto-parts makers such as Lear (NYSE: LEA  ) and Magna International (NYSE: MGA  ) have rocketed this past year, outperforming the S&P 500 with 46% and 56% returns, respectively. Yet Johnson Controls stock has lagged the market average by more than five points. Why?

  • [By Jake L’Ecuyer]

    Magna International (NYSE: MGA) was also up, gaining 2.86 percent to $91.67 after the company reported a 31% rise in its fourth-quarter profit and lifted its dividend.

Top 5 Heal Care Stocks To Watch For 2015: Vertex Pharmaceuticals Incorporated(VRTX)

Vertex Pharmaceuticals Incorporated engages in discovering, developing, manufacturing, and commercializing small molecule drugs for the treatment of serious diseases worldwide. Its products include telaprevir, a prescription medicine used for the treatment of patients with genotype 1 hepatitis C virus (HCV) infection; and Ivacaftor, a prescription medicine used for the treatment of cystic fibrosis. The company markets its products under the INCIVEK brand name in the United States and Canada; INCIVO brand in the United Kingdom, Germany, France, Sweden, Austria, Finland, Denmark, Switzerland, and Norway; KALYDECO brand in the United States; and TELAVIC brand in Japan. Its drug candidates comprise VX-222, a Phase II clinical trial drug candidate, and ALS-2200 and ALS-2158, a Phase I clinical trial drug candidates that are designed to inhibit the replication of HCV; VX-809 and VX-661, a Phase II clinical trial drug candidates that improve the function of defective cystic fibro sis; VX-509, a Phase II clinical trial drug candidate for the treatment of patients with rheumatoid arthritis and other immune-mediated inflammatory diseases; VX-765, a Phase II clinical trial drug for the treatment of epilepsy; and VX-787, an investigational drug candidate for the treatment of influenza A. The company was founded in 1989 and is headquartered in Cambridge, Massachusetts.


Advisors’ Opinion:

  • [By Life Sciences Report]

    AF: On the large-cap side, we like United Therapeutics Corp. (UTHR) and Vertex Pharmaceuticals Inc. (VRTX). United Therapeutics, in particular, has fallen out of favor somewhat, especially relative to the level of investor interest in the name 5-6 years back. Institutional holders have shifted from a largely biotech specialist group to a mix of value and generalist stocks. The upshot is that incremental buying on the part of healthcare specialists, as they re-engage with the name, ought to have a very positive impact on United Therapeutics’ share price.

  • [By Selena Maranjian]

    Vertex Pharmaceuticals (NASDAQ: VRTX  ) jumped 48%, as it looks to expand the application of its promising cystic fibrosis drug, Kalydeco. Vertex recently entered into a dealwith Bristol-Myers Squibbto pursue a treatment for Hepatitis C.

  • [By Keith Speights]

    Here’s another angle: Learn from successful companies. In other words, see what made a given company do well in the market and find others that exhibit similar attributes. There are plenty of companies to choose from, but let’s see how this approach plays out with an example from the biotech world:Vertex Pharmaceuticals (NASDAQ: VRTX  ) . Here are three investment strategy lessons from Vertex’s success.

  • [By Ben Levisohn]

    Shares of Vertex Pharmaceuticals (VRTX) are in free-fall today following yesterday’s earnings-related plunge.

    This time its a downgrade that’s driving Vertex’s stock lower as Bernstein analyst Geoffrey Porges and team cut its shares to Marketperform from Outperform. They explain why:

    Our downgrade is based on the stock’s strong performance over the last nine months (+65%), the high value now accorded to the future expansion in their cystic fibrosis treatment revenue, our caution about the risks associated with the company’s ongoing phase III trials of Vx809 and Kalydeco, and the decreasing probability of any meaningful revenue from their remaining HCV asset, Vx135. While critics will suggest that our downgrade is a timing and valuation one, it seems unreasonable for us to encourage investors to ride out the stock’s volatility, and uncertainty, for programs and results that we expect to only show their full potential in 2015 or 2016, rather than 2014. We believe the stock is fairly valued in the mid $70′s, given the current stage and uncertainty about Vx809. We expect the stock to offer more upside after the company formally transitions their attention from Vx809 to its successor Vx661, and to the three drug combinations containi ng an additional corrector compound for the large number of patients with the commonest form of the disease. The recently announced restructuring was largely inevitable and probably falls short of many investors’ hoped-for cuts in expenses.


    Vertex had surged 62% back on April 19, when it announced trial results for one of its drugs. Now it looks like it’ll try to “fill in the gap”–or trading in the range missed by a big jump (This article on gap trading is a bit dated, but notes that the bigger the gap, the less likely a stock will continue heading in that direction.)

    Vertex has dropped 6.1% to $66.97 today at 2:24 p.m. but it’s f

Top 5 Heal Care Stocks To Watch For 2015: Radware Ltd.(RDWR)

Radware Ltd. provides application delivery solutions and network security solutions to banks, insurance companies, manufacturing and retail, government agencies, media companies, and service providers worldwide. The company offers AppDirector Intelligent Application Delivery Controller for data center optimization and to eliminate traffic surges, server bottlenecks, connectivity disconnects, and downtime for business continuity; and Alteon Application Switch application delivery controller that supports local, global, and transparent load-balance, multi-homing network load-balance, and bandwidth management capabilities. It also provides AppXML, which offers XML and Web services communications for mission-critical applications; AppWall, a Web application firewall (WAF) appliance that secures Web applications; LinkProof that manages wide area networks and Internet traffic for networks; Content Inspection Director, a smart redirection and dynamic policy enforcement device to meet contemporary carrier needs; and Session Initiation Protocol Director, an application delivery controller for application vendors, telecom equipment manufacturers, and system integrators. In addition, the company offers DefensePro Intrusion Prevention and Denial of Service products that protect against worms, bots, viruses, malicious intrusions, and DOS attacks; Inflight, a hardware device that provides online and network-based monitoring solutions; and APSolute Vision, an appliance-based management and monitoring system for information technology staff to centrally manage distributed devices and check the performance and security of enterprise wide application delivery infrastructures. It markets and sells its products primarily through distributors and resellers in North America, Europe, and Asia, as well as directly to select customers in the United States. Radware Ltd. was founded in 1996 and is headquartered in Tel Aviv, Israel.


Advisors’ Opinion:

  • [By Evan Niu, CFA]

    Rival ADC vendor Radware (NASDAQ: RDWR  ) also issued disappointing preliminary results this morning, with its own revenue projected at $45 million — also below its guidance. Radware said sales were strong in the U.S. market but cited weakness in EMEA and China for its weakness.

Top 5 Heal Care Stocks To Watch For 2015: Virginia Heritage Bank (VGBK)


Virginia Heritage Bank is a commercial bank. The Bank serves the greater Washington, D.C. metropolitan area with an emphasis on Northern Virginia. It offers a range of banking services. Its services include free business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as an array of commercial, real estate and consumer loans. Total deposits were $491.7 million at December 31, 2011. Non-interest bearing deposits totaled $57.3 million or 11.66% of total deposits as of December 31, 2011. The Bank has full service branches in Fairfax, Chantilly, Gainesville, Tysons Corner and Dulles, Virginia, and a mortgage division headquartered in Chantilly, Virginia.


Lending Activities

The Banks primary lending focus is real estate finance, as well as making loans to small businesses, professionals and other consumers in its local market area. At Decembe r 31, 2011, approximately 49.3% of the total loan portfolio was composed of commercial real estate loans. The Banks primary lending activities are principally directed to its market area in the greater Washington, D.C. metropolitan area with an emphasis on Northern Virginia. Commercial loans are offered for a variety of business purposes, including government contract receivables, plant and equipment, general working capital, contract administration and acquisition lending. The Bank finances the purchase of commercial real estate properties, such as office buildings and warehouses. A significant portion of the commercial real estate securing the Banks commercial real estate loans at December 31, 2011, was owner-occupied. The Bank has a concentration in loans secured by commercial real estate. At December 31, 2011, its loan portfolio consisted of 49.3% respectively, of commercial real estate loans.


The Banks real estate construction lending segment of it s portfolio is predominately residential in nature and compo! sed of loans with short duration, typically 12 to 24 months. The Bank offers a variety of residential real estate loans both for purchase and refinancing, most of which are sold in the secondary market. It also provides loans to small businesses that may be secured by residential real estate. The Banks residential real estate lending products are available through all of its banking facilities and its mortgage division in Chantilly, Virginia. At December 31, 2011, total residential real estate loans amounted to $53.7 million, excluding loans held for sale of $16.9 million, respectively. The Bank offers an array of consumer loans, including automobile loans, term loans, and overdraft protection.


Investments Securities

As of December 31, 2011, the Banks investment portfolio was classified as available for sale. As of December 31, 2011, investment securities available for sale amounted to $98.8 million. The investment portfolio contained corporat e debt securities amounting to $6.1 million as of December 31, 2011.

Sources of Funds

Deposits are the major source of funding for the Bank. The Bank offers an array of deposit products that include demand, negotiable order of withdrawal (NOW), money market and savings accounts, as well as certificates of deposit.


Advisors’ Opinion:

  • [By CRWE]

    Today, VGBK remains (0.00%) +0.000 at $16.00 thus far (ref. google finance Delayed: 9:30AM EDT July 31, 2013).

    Virginia Heritage Bank previously reported quarterly earnings of $2.5 million after taxes, or $0.55 per share (basic) and $0.54 per share (diluted), for the period ended June 30, 2013. This is a 29% increase over earnings of $1.9 million after taxes, or $0.44 per share (basic and diluted), from the same period a year ago. On a year-to-date basis, earnings were $4.5 million after taxes, or $1.01 per share (basic) and $0.98 per share (diluted) through June 30, 2013 versus $3.3 million after taxes, or $0.76 per share (basic and diluted) in 2012.


    The Banks second quarter results produced an annualized rate of return of 1.25% on average assets and 16.66% on average common equity compared to 1.25% and 15.40%, respectively for the same period a year ago. On a year-to-date basis, the annualized rate of return was 1.15% on average assets and 15.67% on average common equity compared to 1.12% and 13.55%, respectively for 2012.

Top 5 Heal Care Stocks To Watch For 2015: Primco Management Inc (PMCM)

Primco Management Inc., incorporated on October 14, 2010, is a development-stage company. The Company focuses on offering estate management services for its clients and retention on a range of properties including class A office space, industrial, manufacturing, and warehousing facilities as well as data centers and retail outlets for real estate users. In addition, it also focuses on offering consulting services, including site selection, feasibility studies, exit strategies, market forecasts, strategic planning, and research services. In February 2013, the Company announced that ESMG, Inc. took controlling interest in the Company through the acquisition of more than 80% interest of the Company. In February 2013, it purchased the music catalog of D&B Music. In May 2013, the Company acquired Top Sail Productions.


As of December 31, 2010, the Company did not have any operations. During the year ended December 31, 2010, it did not generate any revenues.

Advisors’ Opinion:

  • [By Peter Graham]

    The marijuana field keeps sprouting small cap marijuana stocks like Primco Management Inc (OTCBB: PMCM), Medifirst Solutions Inc (OTCMKTS: MFST) and Modern Mobility Aids, Inc (OTCMKTS: MDRM) which are all trying to seek a high by playing up their connections (no matter how tenuous) to what many consider to be the next high flying sector. But are these small cap marijuana stocks just blowing smoke at investors? Here is a quick reality check:

Top 5 Heal Care Stocks To Watch For 2015: Krispy Kreme Doughnuts Inc (KKD)


Krispy Kreme Doughnuts, Inc. (Krispy Kreme), December 02, 1999, is a retailer and wholesaler of doughnuts complementary beverages and treats and packaged sweets. The Companys principal business is owning and franchising Krispy Kreme stores, at which a variety of doughnuts, including the Companys Original Glazed doughnut, are sold and distributed together with complementary products, and where a broad array of coffees and other beverages are offered. As of February 3, 2013, there were 239 Krispy Kreme stores operated domestically in 38 states and in the District of Columbia, and there were 509 shops in 21 other countries around the world. Of the 748 total stores, 295 were factory stores and 453 were satellites. The Company operates in four segments: Company Stores, domestic franchise stores, international franchise stores, and the KK Supply Chain.


Company Stores

Its Company Stores segment consists of the operating activities of its Company-o wned stores. These stores sell doughnuts and complementary products through the on-premises and wholesale channels. Many of the doughnut varieties the Company offers in its doughnut shops also are distributed, through off-premises sales channels. In addition, it offers a number of products through off-premises channels, including honeybuns, fruit pies, mini-crullers, cupcakes and various chocolate enrobed products, generally packaged as individually wrapped snacks or packaged in snack bags. Krispy Kreme has a beverage program, which includes drip coffees, both coffee-based and noncoffee-based frozen drinks, juices, sodas, milks, water and packaged and fountain beverages. In addition, the Company also develops beverages such as espresso, cappuccino and hot chocolate.


Domestic Franchise

The Domestic Franchise segment consists of the Companys domestic store franchise operations. This segment derives revenue principally from initial development and f ranchise fees related to new stores and from royalties on sa! les by franchise stores. As of February 3, 2013, there were 142 domestic franchise stores in 29 states, consisting of 99 factory and 43 satellite stores.

International Franchise

The International Franchise segment consists of the Companys international store franchise operations. International franchise stores sell doughnuts and complementary products almost exclusively through the on-premises sales channel using shop formats similar to those used in the United States, and also using a kiosk format. A portion of sales by the franchisees in Canada, the United Kingdom and Australia are made to wholesale customers. As of February 3, 2013, there were 509 international franchise shops in 21 countries, consisting of 120 factory stores and 389 satellite shops.


KK Supply Chain Business Segment

The Company operates an integrated supply chain. The KK Supply Chain segment buys and processes ingredients it uses to produce doughnut mixes and manufactures doughnut-making equipment that all factory stores are required to purchase. The Company manufactures doughnut mixes at its facility in Winston-Salem, North Carolina. In addition to traditional doughnut mixes and mixes made from mix concentrate, the Company produces or manages the production of doughnut premix, which is used to produce doughnut mixes in certain international locations. The KK Supply Chain segment also purchases and sells supplies, including icings and fillings, other food ingredients, juices, signage, display cases, uniforms and other items to both Company and franchisee-owned stores.


The Company competes with Dolly Madison, Entenmanns, Hostess, Little Debbie, and Sara Lee.

Advisors’ Opinion:

  • [By Brendan Conway]

    Krispy Kreme Doughnuts’ (KKD) stock has slumped Friday after the chain missed Wall Street’s profit forecasts.ButJanney Capital Marketsis urging clients to take another bite.

    Direct operating expenses were a factor in the final 2Q earnings of 14 cents per share — those costs rose 9.5%. Investors were also met with a disappointing 13% drop in foreign sales. This morning’s media coverage, meanwhile, has focused on the apparent costliness of expanding internationally. “That’s important for a company where its strategy has been to diversify abroad especially to Asia,” writesMiller Tabak & Co. strategistAndrew Wilkinson.


    The Wall Street Journal’s Tom Di Fonzo

    None of that is the focus Friday for Janney’s Mark Kalinowski and Amy Babington, who were impressed with the 10% same-store-sales growth in domestic company-owned stores. As they wrote in a client note:

    Domestic same-store sales trendsremain highly encouraging, with fiscal Q2 comps up by +10.0% for company-ownedstores (just below our high on the sell-side estimate of +10.5%), and by +11.5% forfranchised outlets (above our high on the sell-side projection of +10.5%). Inaddition, Krispy Kreme reveals that for the first three weeks of fiscal Q3 (essentiallyAugust/September/October), same-store sales for U.S. company-owned stores were+5%, +12%, and flat, respectively suggesting a nearly +6% type trend to start fiscalQ3.


    KKD is down more than 14% to $19.95 in Friday afternoon trading. Dunkin’ Brands Group (DNKN), by comparison, has fallen 0.1% to $43.04.

  • [By Sue Chang]

    Krispy Kreme (KKD) is projected to report third-quarter earnings of 15 cents a share, according to a consensus survey by FactSet.

  • [By Dan Caplinger]

    Finally, Krispy Kreme (NYSE: KKD  ) delivered some sweet results for shareholders. Its stock has climbed 20% after it beat earnings expectations and boosted its full-year profit guidance by more than 10%. The donut-making comeback story has been impressive, and the increasing popularity of Krispy Kreme’s coffee and other beverages will be vital to the company’s future success. Given the stock’s valuation, investors clearly believe in the company’s growth story going forward.

  • [By Alex Planes]

    Investors love stocks that consistently beat the Street without getting ahead of their fundamentals and risking a meltdown. The best stocks offer sustainable market-beating gains, with robust and improving financial metrics that support strong price growth. Does Krispy Kreme Doughnuts (NYSE: KKD  ) fit the bill? Let’s take a look at what its recent results tell us about its potential for future gains.

Top 5 Heal Care Stocks To Watch For 2015: ING Groep NV (ING)


ING Groep N.V. (ING), incorporated in 1991, is a global financial institution offering banking, investments, life insurance and retirement services to meet the needs of the customers. The Companys segments include banking and insurance. Banking segment includes retail Netherlands, retail Belgium, ING direct, retail central Europe (CE), retail Asia, commercial banking (excluding real estate), ING real estate and corporate line banking. Insurance segment includes insurance Benelux, insurance central and rest of Europe (CRE), insurance United States (US), Insurance US closed block VA, insurance Asia/Pacific, ING investment management (IM) and corporate line insurance. In February 2011, the Company divested its real estate investment operation ING Real Estate Investment Management (ING REIM) to CB Richard Ellis Group Inc. In June 2011, the Company sold Clarion Partners. In July 2011, ING announced the completion of the sale of Clarion Real Estate Securities. During the year ended December 31, 2011, the Company divested its interests in ING Car Lease and ING IM Philippines. In February 2012, Capital One Financial Corp. acquired ING Direct business in the United States from the Company.


In June 2011, ING had completed the sale of its interest in Chinas Pacific Antai Life Insurance Company Ltd. In June 2011, ING announced the completion of the sale of real estate investment manager of its United States operations, Clarion Partners, to Clarion Partners management in partnership with Lightyear Capital LLC. In October 2011, ING announced that it had completed the sale of REIMs Asian and European operations to CBRE Group Inc. In December 2011 ING completed the sale of its Latin American pensions, life insurance and investment management operations.


Retail Netherlands

Retail Banking reaches its individual customers through Internet banking, telephone, call centers, mailings and branches. Using direct market ing methods, it is a provider of current account services an! d payments systems to provide other financial services, such as savings accounts, mortgage loans, consumer loans, credit card services, investment and insurance products. Mortgages are offered through a tied agents sale force and direct and intermediary channels. ING Bank Netherlands operates through a branch network of approximately 280 branches. It offers a range of commercial banking activities and also life and non-life insurance products. It also sells mortgages through the intermediary channel.


Retail Belgium

ING Belgium provides banking, insurance (life, non-life) and asset management products and services to meet the needs of individuals, families, companies and institutions through a network of local head offices, 773 branches and direct banking channels (automated branches, home banking services and call centers). ING Belgium also operates a second network, Record Bank, which provides a range of banking products through independent banking agents and credit products through a multitude of channels (agents, brokers, vendors).


ING Direct

ING Direct offers a range of financial products, such as savings, mortgages, retail investment products, payment accounts and consumer lending products. It operates in Canada, Spain, Australia, France, Italy, Germany, Austria and the United Kingdom. In June 2011, ING Group announced the sale of ING Direct USA to Capital One Financial Corporation.

Retail Central Europe

Retail Central Europe has a presence in Poland, and Romania and Turkey. ING in Poland is an Internet bank. During 2011, ING Bank Turkey launched the Orange account, the variable savings product. ING in Turkey also launched a mobile phone banking application. ING Bank Romania carried out its Internet banking site, HomeBank. In September 2011, a mobile version of the HomeBank Website was introduced.


Retail Asia

Retail Banking has a presence in Asian markets of India, China and Thailand. As o! f Decembe! r 31, 2011, the Company had 44% interest in ING Vysya and 30% interest in TMB Bank in Thailand. Bank of Beijing (BoB), in which ING has the largest single interest (16.07%) is a commercial bank in China. ING provides principally risk management and retail banking to BoB.

Commercial Banking

ING Commercial Banking supports the banking needs of its corporate and institutional clients to invest both retail and commercial bank customer deposits. It is a commercial bank in its home markets in the Benelux, as well as in Germany, Central and Eastern Europe. In addition to the banking services of lending, payments and cash management and treasury, it also provides solutions in other areas, including specialized and trade finance, derivatives, corporate finance, debt and equity capital markets, leasing, factoring and supply chain finance. Payments and Cash Management (PCM) and General Lending are its some of the product lines. Structured Finance (SF) is a sp ecialist commercial lending business, providing loans to support capital intensive investments and working capital. It is managed in three groups: the Energy, Transport and Infrastructure Group; the Specialized Financing Group; and International Trade and Export Finance. Leasing and Factoring (L&F) provides financial and operating leasing services for a range of equipment, as well as receivables financing and other factoring solutions for commercial banking clients. The Financial Markets (FM) is the global business unit that manages INGs financial markets trading and non-trading activities. FM is managed along three business lines: ALCO manages the interest rates exposures arising from the traditional banking activities, Strategic Trading Platform incorporates the primary proprietary risk taking units, and Clients and Products is the primary customer trading facilitation business line.


Real Estate

During 2011, Real Estate Finance (REF) maintained its credit portfolio. Real Estate Development (ING RED) and! Real Est! ate Investment Management (ING REIM) has a controlled wind down of activities.

Insurance Benelux

Duirng 2011, Nationale-Nederlanden introduced bank pension savings products and annuities. ING Life Belgium introduced a new Universal Life product. Nationale-Nederlanden also received a license from the Dutch Central Bank to launch a defined contribution DC company pension product PPI in Europe. NN Services introduced a processing and information technology system (business process management layer) for several legacy lines of retail Life businesses. NN Services IT manages all the closed book business of Nationale-Nederlanden. INGs life insurance products in the Benelux consist of a range of traditional, unit-linked and variable annuity policies written for both individual and group customers. ING is also a provider of (re-insured) company pension plans in the Netherlands.


NG Benelux non-life products, mainly in the Netherlands, incl ude coverage for both individual and commercial/group clients for fire, motor, disability, transport and third party liability. Nationale-Nederlanden has also a central product manufacturing service for property and casualty insurance, which has developed products for ING Bank in Belgium and ING Bank in the Netherlands. ING offers a range of disability insurance products and complementary services for employers and self-employed professionals (such as dentists and general practitioners).

Insurance Central and Rest of Europe


Insurance Central and Rest of Europe has life insurance companies in Hungary, Poland, the Czech and Slovak Republics, Romania, Bulgaria, Greece, Spain and Turkey. It has pension funds in Poland, Hungary, the Czech and Slovak Republics, Bulgaria, Romania and in Turkey. ING offers a range of individual endowment, unit linked, term and whole life insurance policies designed to meet specific customer needs. It also has employee benef its products, as well as pension funds, that manage individu! al retire! ment accounts for individuals. The latter comprise both mandatory and voluntary retirement savings.


Insurance United States (Excluding US Closed Block Va)

ING Insurance US offers retirement services (primarily defined contribution plans), life insurance, fixed annuities, employee benefits, mutual funds, and broker-dealer services in the United States. ING Insurance US operates four businesses: Retirement Plans, Individual Retirement, Individual Life and Employee Benefits. ING Insurance USs Retirement Plans business is a contribution providers, which offers a range of retirement solutions to all sizes and types of employers, including businesses for-profit ranging from start-ups to large corporations, public and private school systems, higher education institutions, state and local governments, hospitals and healthcare facilities, and not-for-profit organizations. ING Insurance USs Retirement Plans business is a provider of defined contribution (DC) retirement plans in the United States based on assets under management and administration.


Insurance US Closed Block Va

ING US Closed Block VA consists of variable annuities issued in the United States that are primarily owned by individuals and were designed to address the demand for tax-advantaged savings, retirement planning, and wealth-protection. These annuity contracts were sold in the United States, primarily through independent third party distributors, including wirehouses and securities firms, independent planners and agents and banks.

Insurance Asia/Pacific

ING Insurance Asia/Pacific (IAP) is a provider of life insurance products and services. It is a life insurer in the region, with nine life operations in eight markets. IAP has ip operations in Japan and South Korea, operates a nt business in Malaysia, and is well in China, Hong Kong, Macau, India and Thailand. In April 2011, IAP, together with Public B ank Berhad and Public Islamic Bank Berhad, launched a joint ! venture i! n Malaysia, ING PUBLIC Takaful Ehsan Berhad, which will develop Takaful insurance products. In June 2011, IAP completed the sale of its 50% interest in Pacific-Antai Life Insurance Company Limited (PALIC).


The business units of IAP offer select types of life insurance, wealth management, and retail products and services. These include annuities, endowment, disability/morbidity insurance, unit linked/universal life, whole e, participating life, group life, accident and health, term life and employee benefits. In Hong Kong non-life insurance products (including medical, motor, fire, marine, personal accident and general liability) are also offered.

Insurance Latin America

ING completed the sale of its pensions, life insurance and investment management operations on December 29, 2011. These operations were in Chile, Colombia, Mexico, Peru and Uruguay.


ING Investment Management

ING IM is an investment manager of IN G Group with activities in Europe, the Americas, Asia-Pacific and the Middle East. In October 2011, ING IM sold ING IM Australia. ING IM provides a range of actively-managed strategies, investment vehicles and advisory services in all major asset classes and investment styles. It delivers a range of investment strategies and services to INGs global network of businesses and third-party clients.

Advisors’ Opinion:

  • [By WALLSTCHEATSHEET]

    ING is a financial services company providing service to consumers and companies around the world. The company is being forced to sell its South Korean life insurance unit by European regulators. The stock is now trading near highs for the year and looks poised to continue. Over the last four quarters, earnings have been mixed while revenues have been decreasing, however, investors in the company have been pleased with the company’s recent announcement. Relative to its peers and sector, ING has been an average year-to-date performer. Look for ING to OUTPERFORM.

Top 5 Heal Care Stocks To Watch For 2015: Prana Biotechnology Ltd (PRAN)


Prana Biotechnology Limited engages in the research and development of therapeutic drugs for the treatment of neurological disorders in Australia. The company primarily focuses on the Alzheimers, Parkinsons, and Huntingtons diseases, as well as various cancer, age-related macular degeneration and cataract, Motor Neuron, and Creutzfeldt-Jakob diseases. Its development stage product line comprises PBT2, a Phase IIb clinical trial product for the treatment of Alzheimers disease; and PBT2, a Phase IIa clinical trial product for the treatment of Huntingtons disease. The company was formerly known as Prana Corporation Ltd. and changed its name to Prana Biotechnology Limited in January 2000. Prana Biotechnology Limited was founded in 1997 and is based in Parkville, Australia.


Advisors’ Opinion:

  • [By James Brumley]

    SGNT stock is also valued at a palatable trailing P/E of 19.8, and has logged six straight quarterly earnings beats, making it one of the best cheap stocks in the pharmaceutical industry.

    Prana Biotechnology (PRAN)

    It’s a slippery slope when you start placing bets based on a company with no marketable product, and a lead candidate that’s only in Phase 2 trials. But, Prana Biotechnology (PRAN) may be one of those cheap stocks within the drugmaking world that’s worth the risk.

Top 5 Heal Care Stocks To Watch For 2015: RealD Inc(RLD)


RealD Inc., together with its subsidiaries, licenses stereoscopic 3D technologies in the United States, Canada, and internationally. The company designs, manufactures, licenses, and markets its RealD Cinema Systems that enable digital cinema projectors to show 3D motion pictures and alternative 3D content to consumers wearing the company?s RealD eyewear. It also offers RealD Display, active and passive eyewear ,and RealD Format technologies to consumer electronics manufacturers, and content producers and distributors to enable the delivery and viewing of 3D content on high definition televisions, laptops, and other displays. In addition, the company sells CrystalEyes eyewear, monitors, digital light processing television kits, polarizer films, emitters, and linear polarizing systems to companies, government agencies, academic institutions, and research and development organizations for applications in piloting the Mars Rover and in theme park installations. RealD Inc. was founded in 2003 and is headquartered in Beverly Hills, California.

Advisors’ Opinion:

  • [By Rick Aristotle Munarriz]

    Frederic J. Brown, AFP/Getty Images Moviegoers aren’t heading out the multiplex the way they used to, but that doesn’t mean that Hollywood is toast. AMC Entertainment (AMC) reported quarterly results Tuesday. The nation’s leading exhibitor — 345 theaters with 4,976 screens — went public two months ago. The headline numbers are positive. Revenue increased a better than expected 2.3 percent to $713 million. Profitability also expanded nicely. However, revenue increased as a result of a 5.5 percent increase in ticket prices and a 3.7 percent uptick in concessions purchased by patrons. Obviously you don’t see those kind of gains against a mere 2.3 percent lift in revenue without dealing with more empty seats, and that’s just what happened. There was a 3.2 percent decline in attendance. AMC’s ticket takers welcomed 50.4 million guests during the holiday quarter, well below the 52.1 million guests that it entertained a year earlier. That’s bad, and what makes things worse is that it had fewer theaters — from continuing operations — a year earlier. It wouldn’t be wise to hold out for a Hollywood ending. Customers Want Bigger and Better Things Apologists will argue that it wasn’t a bumper crop of movies hitting theaters, but that’s not accurate at all. Last year’s biggest box office winner — “The Hunger Games: Catching Fire” — opened in November. Disney’s “Frozen” also opened ahead of the holidays, and it’s the family entertainment giant’s biggest non-Pixar earner since 1994’s “The Lion King.” Moviegoers still come out for the big movies, and they’re also willing to pay more for a premium setting. IMAX (IMAX) reported blowout quarterly results a few days earlier. IMAX screens rang up a record $244 million in ticket sales worldwide. IMAX is also closing out the year with a record backlog of 384 commercial theaters to deploy. RealD (RLD) is also holding up nicely as a leading provider of 3-D systems for exhibitors. It enjoyed a major boost with “Gravity,” a

Top 5 Heal Care Stocks To Watch For 2015: CTC Media Inc.(CTCM)

CTC Media, Inc., together with its subsidiaries, operates as an independent media company. It operates the CTC, Domashny, and Peretz television networks in Russia. The company also operates Channel 31, a television network in Kazakhstan, as well as a television channel in Moldova offering entertainment programming. In addition, it is involved in in-house production operations that focus on series, sitcoms, and shows. CTC Media, Inc. was founded in 1989 and is headquartered in Moscow, the Russian Federation.

Advisors’ Opinion:

  • [By Halia Pavliva]

    The Bloomberg Russia-US gauge slipped 0.4 percent to 104.16, paring its advance this month to 7.7 percent. CTC Media Inc. (CTCM), the Nasdaq-listed Russian television company, rallied 2.6 percent to $12.86, the highest level since April 25. The stock has climbed 22 percent this month, making it the best performer on the Bloomberg-Russia gauge. VimpelCom is the second-biggest gainer on the index this month, followed by OAO Rostelecom (ROSYY), which has increased 17 percent after two months of declines.

  • [By Dan Burrows]

    This small-cap media company operates three popular television networks in Russia, but that’s not all CTC Media (CTCM) has going for it. Billionaire owner Yury Kovalchuk is a longtime pal of President Vladimir Putin. That’s important in a country as, er, mercurial as Russia.

Top 5 Heal Care Stocks To Watch For 2015: Accor SA (AC)

Accor SA is a France-based hotel operator. The Hotels division manages more than 531,000 bedrooms in more than 4,200 hotels across 90 countries. Accor’s portfolio consists of such hotel brands as Sofitel, Pullman, Novotel, Mercure, Suite Novotel, Adagio, ibis Styles, all seasons, Etap Hotel, Formule 1, hotelF1, Studio 6 and Motel 6, and its related activities, Thalassa sea & spa and Lenotre that provide an offer ranging from luxury to budget class. It operates through a number of subsidiaries, including SH Danton Michelet, Ste De Constructiondes Holets Suites, SIET, The Newgen Hotels, Chammans, Profid, SPFH, IBL, Soluxury HMC and SNC SH 61 QG; LA THERMALE DE FRANCE, PIH and HOTEXCO, among others. On July 30, 2012, it divested its stake in Ascendas Australia Hospitality Fund and Beijing Sanyuan Novotel and Ibis. In February 2013, it sold the Sofitel Paris Le Faubourg. In August 2013, it opened a new hotel in Thailand. In September 2013, it opened new resort in Dubai. Advisors’ Opinion:

  • [By Namitha Jagadeesh]

    Accor SA (AC) declined 4.2 percent to 25.62 euros after Credit Suisse Group AG downgraded Europes largest hotel operator to underperform, the equivalent of sell, from outperform, citing the increasing risk of disappointing first-quarter earnings.

  • [By Corinne Gretler]

    Accor (AC) dropped 4.4 percent to 27.52 euros, the biggest loss since June 2012. Europes largest hotel operator posted first-half earnings before interest and taxes of 198 million euros ($265 million), missing the average analyst projection of 212 million euros. The company predicted 2013 Ebit of between 510 million euros and 530 million euros, compared with the average 534 million-euro analyst estimate.

  • [By Inyoung Hwang]

    Accor (AC) dropped 3.9 percent to 32.27 euros, its biggest decline since Aug. 28. Europes largest hotel operator said it will reorganize its business into two separate units. The HotelServices unit will operate about 460,000 hotel rooms under 14 brands. The HotelInvest unit will act as the owner and investor in hotels.